Meningitis surveillance and vaccination coverage updates. Meningococcal B vaccine introduction in Europe

Speaker: George Syrogiannopoulos

Duration: 0:24:09
Learning objectives: At the end of the video, viewers will: (1) Learn that currently Neisseria meningitidis (meningococcus) and pneumococcus are the two most common etiologic agents of bacterial meningitis in Europe. (2) Understand the overall burden of meningococcal disease and the role of the different meningococcal serogroups with serogroup B being the predominant one in Europe. (3)Learn that recently, two new meningococcal serogroup B protein vaccines have been available. (4)Learn that MenB-4C vaccine has been approved in Europe and universal vaccination of young infants has been initiated in the UK. (5) Understand the accumulating data on the immunogenicity, safety and effectiveness of MenB-4C vaccine in different areas of the world.

Be the first to comment

Please check your e-mail for a link to activate your account.

connect

get updates